CAS: 1510712-69-2
| Marca | Dados do produto | Pureza | Gama de preços | Estimativa de entrega |
|---|---|---|---|---|
 | Glycine,N-[4-[[6-amino-2-(butylamino)-7,8-dihydro-8-oxo-9H-purin-9-yl]methyl]benzoyl] REF: 3D-KKC71269CAS: 1510712-69-2 | Min. 95% | A consultar | Sex 24 Jan 25 |
 | CL264 REF: TM-T10833CAS: 1510712-69-2 | 97.14% | 85,00 €~1.820,00 € | Sex 31 Jan 25 |
![Glycine,N-[4-[[6-amino-2-(butylamino)-7,8-dihydro-8-oxo-9H-purin-9-yl]methyl]benzoyl]](https://static.cymitquimica.com/products/3D/thumb/KKC71269.jpg)
Glycine,N-[4-[[6-amino-2-(butylamino)-7,8-dihydro-8-oxo-9H-purin-9-yl]methyl]benzoyl]
CAS:1510712-69-2
Please enquire for more information about Glycine,N-[4-[[6-amino-2-(butylamino)-7,8-dihydro-8-oxo-9H-purin-9-yl]methyl]benzoyl] including the price, delivery time and more detailed …
Fórmula:
C19H23N7O4
Pureza:
Min. 95%
Peso molecular:
413.4 g/mol
Ref: 3D-KKC71269
| 10mg | A consultar | ||
| 25mg | A consultar | ||
| 50mg | A consultar |
Entrega estimada em Estados Unidos, Sexta-feira 24 de Janeiro de 2025
CL264
CAS:1510712-69-2
CL264, a selective agonist of TLR7, can be used in studies about innate immune signals.
Fórmula:
C19H23N7O4
Pureza:
97.14%
Cor e Forma:
Solid
Peso molecular:
413.43
Ref: TM-T10833
| 1mg | 85,00 € | ||
| 5mg | 182,00 € | ||
| 10mg | 313,00 € | ||
| 25mg | 496,00 € | ||
| 50mg | 686,00 € | ||
| 100mg | 911,00 € | ||
| 500mg | 1.820,00 € | ||
| 1mL*10mM (DMSO) | 205,00 € |
Entrega estimada em Estados Unidos, Sexta-feira 31 de Janeiro de 2025
